<i>CTSZ</i> SNPs significantly associated with TB severity in Ugandan household contact study cohorts, sorted by ascending <i>p</i>-value. by Rachel K. Meade (22216529)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

DataSheet_1_Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK f... by Kawaljit Kaur (1496686)

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Summary of modelling methods—incorporating real-world data into colorectal cancer burden calculations. by Joachim Worthington (8394213)

Subjects:

Increased or reduced ATGL-1 activity does not significantly change <i>N. parisii</i> growth. by Hala Tamim El Jarkass (16625309)

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Age-specific numbers and rates of DALYs (A) and deaths (B) for <i><i>Klebsiella pneumoniae</i></i> associated LRI burden by sex, 2021. DALYs disability-adjusted life years. by Juanjuan Li (399633)

Subjects:

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

Subjects:

Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

Subjects:

Pre-treatment of OJS did not mitigate DRG activation but decreased inflammatory responses in BMDM. by Patrice Cunningham (12914917)

Infection at a later timepoint still enables tumour growth restriction but previous infection reverses the effect. by Philine Steinbach (17847521)

Subjects:

Predictions of Age-Standardized Rate of burden caused by fire, heat and hot substances for different sexes in 2030 based on the Bayesian Age-Period-Cohort model. by Shi Huang (125861)

Dose dependent mutation burden in wild-type and DNA repair mutants. by Bettina Meier (274833)

Loss of capsule significantly reduces <i>N</i>. <i>musculi</i> bacterial burden in the mouse oral cavity but not the gut during persistent colonization. by Katherine A. Rhodes (12557806)

“…Total oral bacterial burden is significantly decreased in animals inoculated with the Δ<i>228cps</i> mutant in comparison to Wt controls (Kruskal Wallis test with Dunn’s comparison, * <i>p</i> = 0.0178, comparisons denoted by brackets in the legend), while no significant difference is observed in samples isolated from the gut. …”

Fomepizole treatment decreases the NAD(H) pool, impairs ATP production, and enhances ribosomal targeting antibiotic efficacy. by Hansol Im (14803255)

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. by Hala Tamim El Jarkass (16625309)

Age standardized incidence rates of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

The number and ASR of deaths for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

Subjects:

The number and ASR of DALYs for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

Subjects: